Portfolio company
Stemnovate
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops human cell-based platforms for drug discovery and toxicity testing to support pharmaceutical firms and research institutions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cellbox Labs
This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.
StemoniX
This deep-tech company develops human stem cell-derived organoid platforms for pharmaceutical and biotechnology customers to conduct drug discovery and toxicity screening.
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
Cytochroma
This company manufactures genetically diverse stem cell-derived mini-organs to provide animal-free drug safety and efficacy testing for pharmaceutical and biotechnology organisations.
DropPrint Genomics
This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.
Oncosyne
This company develops patient-derived tumoroid drug screening platforms for pharmaceutical firms and oncologists to improve drug discovery and personalised cancer treatment.
Toxometris.ai
This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
